CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-28 | COLES N ANTHONY Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,145 | 0 | ||
| 2022-12-28 | COLES N ANTHONY Director | Option exercise · Non-Qualified Stock Option (right to buy) | −3,613 | 0 | ||
| 2022-12-20 | VAGELOS P ROY Director | Other disposition | −30 | $728.86 | $22K | 2,072 |
| 2022-12-20 | VAGELOS P ROY Director | Other disposition | −111 | $729.71 | $81K | 1,961 |
| 2022-12-16 | VAGELOS P ROY Director | Grant or award | +1,651 | 324,083 | ||
| 2022-12-16 | VAGELOS P ROY Director | Grant or award · Non-Qualified Stock Option (right to buy) | +16,254 | 16,254 | ||
| 2022-12-16 | Van Plew Daniel P EVP & General Mgr, Industrial | Grant or award | +3,798 | 33,884 | ||
| 2022-12-16 | Van Plew Daniel P EVP & General Mgr, Industrial | Grant or award · Non-Qualified Stock Option (right to buy) | +14,019 | 14,019 | ||
| 2022-12-16 | STAHL NEIL EVP Research and Development | Grant or award | +1,101 | 53,100 | ||
| 2022-12-16 | STAHL NEIL EVP Research and Development | Grant or award · Non-Qualified Stock Option (right to buy) | +4,063 | 4,063 | ||
| 2022-12-16 | MURPHY ANDREW J EVP Research | Grant or award | +4,129 | 60,747 | ||
| 2022-12-16 | MURPHY ANDREW J EVP Research | Grant or award · Non-Qualified Stock Option (right to buy) | +15,238 | 15,238 | ||
| 2022-12-16 | McCourt Marion EVP Commercial | Grant or award | +2,973 | 22,079 | ||
| 2022-12-16 | McCourt Marion EVP Commercial | Grant or award · Non-Qualified Stock Option (right to buy) | +10,971 | 10,971 | ||
| 2022-12-16 | LAROSA JOSEPH J EVP General Counsel and Secret | Grant or award | +2,752 | 23,110 | ||
| 2022-12-16 | LAROSA JOSEPH J EVP General Counsel and Secret | Grant or award · Non-Qualified Stock Option (right to buy) | +10,159 | 10,159 | ||
| 2022-12-16 | Landry Robert E EVP Finance CFO | Grant or award | +3,853 | 32,844 | ||
| 2022-12-16 | Landry Robert E EVP Finance CFO | Grant or award · Non-Qualified Stock Option (right to buy) | +14,222 | 14,222 | ||
| 2022-12-16 | Fenimore Christopher R. SVP Controller | Grant or award | +1,926 | 18,581 | ||
| 2022-12-16 | Fenimore Christopher R. SVP Controller | Grant or award · Non-Qualified Stock Option (right to buy) | +7,111 | 7,111 |
Page 62 of 105 · 2,088 trades